SAR evolution and discovery of benzenesulfonyl matrinanes as a novel class of potential coxsakievirus inhibitors.
暂无分享,去创建一个
Jian-Dong Jiang | Xin A. Zhang | Sheng Tang | Yu-huan Li | Danqing Song | Hui-qiang Wang | Xin-yue Cheng | Lan-ying Kong | Yinghong Li
[1] Dajun Zhang,et al. Formononetin inhibits enterovirus 71 replication by regulating COX- 2/PGE2 expression , 2015, Virology Journal.
[2] Jian-Dong Jiang,et al. Novel N-benzenesulfonyl sophocarpinol derivatives as coxsackie B virus inhibitors. , 2015, ACS medicinal chemistry letters.
[3] X. Che,et al. Nephrotic syndrome in hand, foot and mouth disease caused by coxsackievirus A16: a case report. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[4] R. Shao,et al. Synthesis and biological evaluation of sophoridinol derivatives as a novel family of potential anticancer agents. , 2014, ACS medicinal chemistry letters.
[5] W. Palmer,et al. Hand, foot, and mouth disease: Identifying and managing an acute viral syndrome , 2014, Cleveland Clinic Journal of Medicine.
[6] R. Shao,et al. Novel N-substituted sophoridinol derivatives as anticancer agents. , 2014, European journal of medicinal chemistry.
[7] Jian-Dong Jiang,et al. Synthesis and Biological Evaluation of N‐Substituted Sophocarpinic Acid Derivatives as Coxsackievirus B3 Inhibitors , 2013, ChemMedChem.
[8] Jian-Dong Jiang,et al. The antiviral effect of 7-hydroxyisoflavone against Enterovirus 71 in vitro , 2013, Journal of Asian natural products research.
[9] Jian-Dong Jiang,et al. N-Substituted Benzyl Matrinic Acid Derivatives Inhibit Hepatitis C Virus (HCV) Replication through Down-Regulating Host Heat-Stress Cognate 70 (Hsc70) Expression , 2013, PloS one.
[10] E. De Clercq. Highlights in antiviral drug research: antivirals at the horizon. , 2013, Medicinal research reviews.
[11] A. Ko,et al. Antiviral Effects of Small Interfering RNA Simultaneously Inducing RNA Interference and Type 1 Interferon in Coxsackievirus Myocarditis , 2012, Antimicrobial Agents and Chemotherapy.
[12] F. Widdel,et al. Stereochemical investigations reveal the mechanism of the bacterial activation of n-alkanes without oxygen. , 2012, Angewandte Chemie.
[13] Jian-Dong Jiang,et al. Design and synthesis of oxymatrine analogues overcoming drug resistance in hepatitis B virus through targeting host heat stress cognate 70. , 2011, Journal of medicinal chemistry.
[14] A. Reynolds,et al. Design, synthesis, and structure-affinity relationships of regioisomeric N-benzyl alkyl ether piperazine derivatives as sigma-1 receptor ligands. , 2010, Journal of medicinal chemistry.
[15] J. Neyts,et al. 9-Arylpurines as a novel class of enterovirus inhibitors. , 2010, Journal of medicinal chemistry.
[16] W. Kiosses,et al. Viral Persistence and Chronic Immunopathology in the Adult Central Nervous System following Coxsackievirus Infection during the Neonatal Period , 2009, Journal of Virology.
[17] E. De Clercq,et al. Selective inhibitors of picornavirus replication , 2008, Medicinal research reviews.
[18] B. McManus,et al. The impact of CVB3 infection on host cell biology. , 2008, Current topics in microbiology and immunology.
[19] D. Barnard,et al. Current status of anti-picornavirus therapies. , 2006, Current pharmaceutical design.
[20] A. Ramsingh,et al. Coxsackievirus-induced pancreatitis. , 2004, Viral immunology.
[21] H. Rotbart,et al. Treatment of picornavirus infections. , 2002, Antiviral research.
[22] N. Chapman,et al. The group B coxsackieviruses and myocarditis , 2001, Reviews in medical virology.
[23] L. Kinnunen,et al. Molecular epidemiology and evolution of coxsackievirus A9. , 2000, The Journal of general virology.
[24] T. Hyypiä,et al. Molecular comparison of coxsackie A virus serotypes. , 1995, Virology.
[25] S. Tracy. A comparison of genomic homologies among the coxsackievirus B group: use of fragments of the cloned coxsackievirus B3 genome as probes. , 1984, The Journal of general virology.